NZX/ASX Annoucements

TruScreen Investor Presentation March 2025

Key Markets Update and Revenue Guidance

TruScreen Signs MOU with Hangzhou Dalton Bioscience to Expand HPV Product Offerings

TruScreen has signed a non-binding Memorandum of Understanding (“MOU”) with Hangzhou Dalton Bioscience Limited [DaltonBio], a leading China based manufacturer of high performance HPV DNA tests and laboratory equipment for cervical cancer screening. The MOU provides a framework for collaboration to...

TruScreen appoints a distributor in Indonesia

TruScreen Presents at WHO Global AI Collaboration Meeting

TruScreen has presented at a World Health Organisation (WHO) global meeting to investigate further the use of AI technologies for screening of cervical cancer. TruScreen’s unique AI enabled technology was the only opto-electric tissue differentiating medical device company invited to...

TruScreen Half Year Results

TRUSCREEN GROUP LIMITED Interim Unaudited Financial Statements For the Six Months Ended 30 September 2024

Screening Program in Vietnam

November Newsletter

Germany’s Springer Nature Journal Publication on TruScreen

TruScreen Ranked in Top 6 Women’s Health Startups Globally

TruScreen is featured in a UNITAID report

TruScreen Appoints Dexter Cheung as Chair of Technology Committee

Results of Annual General Meeting

Annual Shareholders Meeting Presentation

TruScreen outperforms Pap Smear in Saudi Arabia Study

TruScreen Pty Ltd – Change of Operations Address

TruScreen has moved into a new office in Lane Cove West

TruScreen Commences Major Commercial Rollout in Vietnam

Commercial activities ramp up in Vietnam after the MOH listing of TruScreen 065c789v948zsw (1)

TruScreen Annual Report FY2024

TruScreen Annual Report and Finacial Statement for Finacial Year 2024 TRU Annual Report - FY2024

TruScreen Wins Top Prize in Poland’s Institute for Mother and Child Startup Challange

NZX | ASX - GENERAL  

TruScreen included on the Vietnamese Ministry of Health Approved Technology List 

NZX | ASX - MKTUPDATE  

TruScreen Awarded Zimbabwe Tender

NZX | ASX - GENERAL

TruScreen Half Year Results

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

TruScreen Half Year Results Template

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

Appendix 2A

ASX - Appendix 2A

Appendix 3G

ASX - Appendix 2A

Capital Change Notice

NZX | ASX - SHINTR

Director and Officer Disclosure Notice

NZX | ASX - SHINTR

Strong Sales Growth in China in Improved Half Year Results

NZX | ASX - GENERAL

TruScreen – Commercial Breakthrough in Saudi Arabia

NZX | ASX - GENERAL

Shareholder Meeting Results

NZX | ASX - MEETING

Annual Meeting Presentation

NZX | ASX - MEETING

TruScreen Stakeholder Newsletter August 2023

NZX | ASX - GENERAL

Strong Sales growth in Q1 FY2024 (April to June 2023)

NZX | ASX - GENERAL

TruScreen Opto-electrical Technology Recognised

NZX  |  ASX  - GENERAL

Truscreen Annual meeting Notice

NZX | ASX - MEETING

Director and Officer Change of Interest Notice

NZX | ASX - SHINTR

Annual Report FY2023

NZX | ASX - ANNREP

TruScreen Preliminary Final Results March 2023

NZX  - FLLYR 

TruScreen Preliminary Results March 2023 Announcement

NZX | ASX - FLLYR

TruScreen Preliminary Final Results Summary

NZX | ASX - FLLYR

CSCCP Cervical Cancer Screening Guideline to Include TruScreen Technology

NZX | ASX - GENERAL

TruScreen Recognised in Authoritative China Blue Paper

NZX | ASX - GENRAL

Director and Officer Change of Interest Notice

NZX | ASX - SHINTR

Growing Recognition for TruScreen

NZX | ASX - GENERAL

Director and Officer Disclosure Notices

NZX | ASX - SHINTR

Appendix 2A

ASX - Appendix 2A

Capital Change Notice

NZX  - SHINTR

TruScreen Rights Offer closes

NZX | ASX - TRU

Outstanding Clinical Evaluation Results from Saudi Arabia

NZX | ASX - GENERAL

TruScreen Rights Issue Offer Closing Soon

NZX | ASX - OFFER

Publication of Research Report

NZX | ASX - GENERAL

China Ramps Up for Public Health Check Centres

NZX | ASX - GENERAL

TruScreen Raises $600,000 in Initial Share Placement

NZX | ASX - OFFER

TruScreen Rights Issue Offer Opens

NZX | ASX - OFFER

Pro Rata Renounceable Rights Issue Offer Document

NZS | ASZ  - OFFER

TruScreen to Lodge a Pro Rata Renounceable Rights Issue

ASX | NZX - OFFER

Cleansing Notice

ASX | NZX - OFFER

TruScreen Corporate Action Notice

NZX | OFFER

Commercial Update

NZX | ASX - GENERAL

Market Update

ASX | NZX - GENERAL

Director and Officer Disclosure Notice – Mr Christopher Horn

NZX | ASX - SHINTR

Director and Officer Disclosure Notice – Mr Anthony Ho

NZX | ASX - SHINTR

TruScreen Half Year Results Template

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

TruScreen Half Year Results

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

TruScreen Market Update

NZX | ASX - GENERAL

TruScreen Stakeholder Newsletter November 2022

NZX | ASX - GENERAL

Hosts Global Medical Symposium, Expands Reach in Vietnam

NZX | ASX - GENERAL

Director and Officer Disclosure Notice

NZX | ASX - SHINTR

Director and Officer Disclosure Notice

NZX | ASX - SHINTR

Dr Beata Edling Appointed CEO of TruScreen Group

NZX | ASX - GENERAL

Shareholder Meeting Results

NZX | ASX - MEETING

Annual Meeting Presentation

NZX | ASX - MEETING

TRU Signs Five Year Manufacturing Agreement for SUS Supply

NZX | ASX - GENERAL

Director and Officer Disclosure Notice

NZX - SHINTR

Relaunch of TruScreen Devices in Xinjiang Uygur Region

NZX | ASX - GENERAL

TruScreen-based cervical cancer screening centre opens in Mexico City

NZX | ASX - GENERAL

TruScreen Shareholder Meeting

NZX | ASX - MEETING

TruScreen Director Nominations Closing Date

NZX | ASX - MEETING

SPH Notice – Waitara Trustees Limited

NZX - SHINTR

Director & Officer Disclosure Notice

NZX | ASX - SHINTR

Annual Report FY2022

NZX | ASX - ANNREP

Director & Officer Disclosure Notice

NZX | ASX - SHINTR

Director & Officer Disclosure Notice

NZX | ASX - SHINTR

Director & Officer Disclosure Notice

NZX | ASX - SHINTR

TruScreen FY22 Preliminary Results

NZX | ASX - FLLYR

Provision for Impairment of Non Current Assets

NZX | ASX - GENERAL

COGA Trial validates superiority of TruScreen cervical cancer screening method

NZX | ASX - MKTUPDATE

Capital Change Notice

NZX | ASX - SHINTR

TruScreen achieves significant milestones with Distributors

NZX | ASX - MKTUPDATE

Disclosure of Directors and Senior Managers Relevant Interests

NZX  |  ASX - SHINTR

Issue of Unlisted Options

NZX  |  ASX - SECISSUE

TruScreen Makes Progress in Key Markets Worldwide

NZX  |  ASX  -  General, Progress Report

Half Year Report September 2021

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

TruScreen Results Announcement Template September 2021

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

TruScreen September 2021 Results Announcement

NZX  |  ASX  -  HALFYR |  Half Yearly Report, Half Year Accounts 

TruScreen Device – Milestones Achieved on Growth Strategy

NZX | ASX - MKTUPDATE

Clinical Trial Results Highlight Efficacy of TRU Technology

NZX | ASX - GENERAL

Director and Officer Disclosure Notice

NZX | ASX - SHINTR

Ceasing to be Substantial Shareholder Browns Island Holdings Limited

NZX | ASX - SHINTR

Stakeholder Newsletter – May 2021

NZX | ASX - General | Periodic Reports - Other, Progress Report, Letter to Shareholders

Preliminary Final Report March 2021

NZX | ASX - FLLYR | Preliminary Final Report

Appendix 4E & Preliminary Final Results March 2021

ASX -  Preliminary Final Report

Prelim Results FY2021

NZX  - FLLYR 

Preliminary Results Announcement

NZX | ASX - FLLYR | Preliminary Final Report

Final Director’s Interest Notice

NZX | ASX - SHINTR

Director and Officer Disclosure Notice

NZX | ASX - SHINTR

TruScreen Board Appointment

NZX | ASX - ADMIN

TruScreen Executive Leadership Change

NZX | ASX - SHINTR

SPH Notice – Masfen Securities Limited and Others

NZX - SHINTR

Capital Change Notice

NZX - SHINTR

Substantial Shareholder Notice – Browns Island Holdings Limited

NZX - SHINTR

Substantial Shareholder Notice – Consolidated Nominees Pty Ltd

NZX - SHINTR

Change of Director’s Interest Notice

ASX - Change of Director's Interest Notice

Annual Report for the year ended 31 March 2020

ASX - Period Reports | ASX Admission to Official List

Top 20 Shareholders List

ASX - Top 20 Shareholders | Admission to Official List

Distribution Schedule

ASX - Issued Capital | Admission to Official list

Reviewed pro-forma statement of financial position

ASX - Period Reports | Admission to Official list

Accounts for the six months ended 30 September 2020

ASX - Periodic Reports | Admission to Official List

Annual Report for the year ended 31 March 2019

ASX - Period Reports | Admission to Official List

Constitution

ASX - Admission to Official List | Constitution

Information Form and Checklist Annexure 2

ASX - Admission to Official List | Company Administration - Other

Information Form and Checklist

ASX - Admission to Official List | Company Administration - Other

Appendix 1C

ASX - Issued Capital - Other | Admission to Official list

ASX Market Announcement – Admission and Quotation

ASX - Admission to Official List | Commencement of Official Quotation

Offer Closes Significantly Oversubscribed

NZX - OFFER

ASX Approves TruScreen to Official List – Offer to Close 18 December 2020

NZX - OFFER

Public Offer Acceptance Reaches Target NZ$1.5 Million

NZX - OFFER

Opening of Public Offer and Publication of Research Report

NZX - OFFER

Application for Dual Listing of TruScreen’s Shares on the ASX

NZX - GENERAL

TruScreen Unaudited Interim Condensed Financial Statements 30 September 2020

NZX - INTERIM

TruScreen Results Template 30 September 2020

NZX - INTERIM

TruScreen Results Half Year Ended 30 September 2020

NZX - INTERIM

Recording of TruScreen Group Limited ASM Virtual Meeting

NZX - MEETING

Annual Meeting of Shareholders Results

NZX - MEETING

Juliet Hull Elected Non-Executive Director

NZX - ADMIN

Truscreen Strengthens Market Presence in Central Europe

NZX - GENERAL

Truscreen Director Nominations Closing Date

NZX - MEETING

Truscreen Stakeholders Newsletter July 2020

NZX - GENERAL

Truscreen NZX Results Announcement Form March 2020

NZX - ANNREP

Truscreen Financial Results for the year ended 31 March 2020

NZX - ANNREP

Truscreen Capital Change Notice

NZX | Truscreen-Capital-Change-Notice

Truscreen Priority Allocation of $1 Million Closed

NZX - OFFER

Results Announcement Date – Reliance on NZX Class Waiver

NZX - GENERAL

Truscreen Capital Change Notice

NZX - SECISSUE

Director Disclosure Notices

NZX - SHINTR

Truscreen Closes Public Pool Offer Fully Subscribed

NZX - OFFER

Director’s Certificate

NZX

Truscreen Limited Capital Change Notice

NZX 

TruScreen Key Investment Highlights

NZX - OFFER 

Notice of Offer of Same Class Financial Products for Issue

NZX - OFFER 

Truscreen expands in China

NZX - MKTUPDTE

Truscreen Limited Corporate Action Notice

NZX - GENERAL 

Offer Booklet

NZX - OFFER 

Truscreen Investor Presentation

NZX - SHINTR

TruScreen expands to Vietnam with Ministry of Health Approval

NZX- GENERAL

Appointment of Auditors

NZX - AUDITORS

TruScreen Appoints Ex-Johnson & Johnson UK Executive as CEO

NZX - GENERAL

TruScreen Manufacturing and Supply Chain Update

NZX - GENERAL 

Outstanding Results from Truscreen Indian Screening Trial

NZX - GENERAL

TruScreen Unaudited Preliminary Results for the Half Year Ending 30 September 2019

TruScreen Interim Results to 30 September 2019

November 2019 Newsletter

WHO cervical cancer elimination strategy opens up TruScreen’s market opportunity

Interim Unaudited Financial Statements

Resignation of Chief Executive Officer

Unlisted Options Issue

Director and Officer Disclosure Notices

Issue of Securities

Screening results in Hunan, China exceed expectations

Director Ongoing Disclosure Notice

TRU July Newsletter

TruScreen Director’s Certificate

TruScreen Share Issue

TruScreen Director Nominations Closing Date

TruScreen Completes Capital Raising

Memorandum

TruScreen Trading Halt

TruScreen Limited 2019 Annual Report

TruScreen Market Update

Cervical Cancer Technology Landscape – Unitaid & WHO Publication

Preliminary Financial Statements

TruScreen FY19 results show sales up, costs down, reduced loss

TruScreen Preliminary Results FY19 Appendix

World Health Organisation Recognises TruScreen Cervical Cancer Screening Device

Investor Update

Market Update – March 2019

TruScreen Significant Sales Increase, Reduced Loss in Half Year

TruScreen Preliminary Results

TruScreen Interim Results to 30 Sept 2018

Waivers and Rulings for Migration to NZX Main Board

L&Q Notice: TruScreen Limited Ordinary Shares (“TRU”)

TruScreen December Newsletter

TRU Migration from NZAX Market to NZX Main Board

TRU Appoints CFO and Company Secretary

TRU Appointment of Alternate Director

TruScreen Reports 523% Sales Growth for First Half Year

TruScreen Announces New Chairman

Shareholder Presentation Annual Meeting 2018

TruScreen Annual Meeting

TruScreen’s Annual Meeting – Chairman’s Presentation

Results of Annual Shareholder Meeting

TruScreen Share Purchase Plan Details

TruScreen HIV African Initiative Update

TruScreen Announces Share Purchase Plan Details

Director’s Resolutions

TruScreen Share Placement September 2018

TRU Capital Raising August 2018

TruScreen Announces HIV African Initiative

Truscreen Limited – 2018 Annual Report

2018 Annual Review Letter

TruScreen Limited: Annual Report and Section 209C Notice

TruScreen Commences Large Scale Chinese Pilot with CDC

TruScreen’s New Production Facility Fully Operational & Delivers Significant Improvement In Device Profitability

TruScreen Makes Strong Progress in First Quarter FY19

Preliminary Consolidated Financial Statements NZX Appendix

Preliminary Consolidated Financial Statements

TruScreen Unaudited Preliminary Results for the Year Ended 31 March 2018

TruScreen June Newsletter

Cancer Marketing Expert Joins TruScreen Board

TruScreen Appoints New Director

TruScreen Half Year Report and Interim Financial Statements

TruScreen January Newsletter

Resignation of Director

TruScreen Receives CFDA Approval for its Second Generation Device in China

TruScreen Passes CFDA Technical Assessment for its Second Generation Device in China

World-renowned medical specialist joins TruScreen Board 19 October 2017

Annual Meeting of Shareholders

TruScreen Director Nominations Closing Date

TruScreen Annual Report 2017

TruScreen Preliminary Results for the Year Ended 31 March 2017

TruScreen Limited Preliminary Consolidated Financial Statements

TruScreen Limited NZX Appendix 1 Release

TruScreen April 2017 Newsletter

TruScreen Investor Briefing Presentation March 2017

TruScreen Interim Results to 30 September 2016